Intraoperative Imaging Market to Surpass US$ 1.53 Billion Threshold by 2025, With the Introduction of New Advance Intraoperative Imaging Devices - Coherent Market Insights

The global intraoperative imaging market by device type (mobile C-arms, intraoperative MRI, intraoperative CT, and intraoperative ultrasound), by application (neurosurgery, orthopedic surgery, spine Surgery, cardiovascular, ENT, Gastro, and Others), by end user (hospitals and ambulatory surgical centers), and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1.53 billion in 2016 and is projected to expand at a CAGR of 4.7% during the forecast period (2017 - 2025). High prevalence of several diseases such as cardiovascular diseases, osteoarthritis disorder and cancer expected to be major driving factors for growth of the intraoperative imaging market during the forecast period. Moreover, various types of cancer such as brain tumors and intracranial tumors require complete removal tumor through surgery and implantation. Such increase in number of treatments for cancer is a key factor contributing to the market growth.

According to Cancer Australia estimates, around 1,405 new cases of brain cancer are expected in 2017. Moreover, according to the World Health Organization (WHO), cardiovascular diseases (CVD) is a leading cause of mortality worldwide. Furthermore, according to Centers for Disease Control and Prevention (CDC), in the U.S., 1 out 4 people suffer from osteoarthritis. Moreover, according to the WHO estimates, by 2050, around 130 million people are expected to suffer from osteoarthritis worldwide. Thereby, high prevalence of cardiovascular diseases and osteoarthritis cases demands proper treatment management in order to maximize patient outcomes. This is expected to anticipate growth of intraoperative imaging market over the forecast period. In 2014, the IMRIS, Inc. received the Therapeutic Goods Administration (TGA) regulatory approval for its VISIUS iCT for sales and marketing in Australia. VISIUS iCT, the one and only ceiling-mounted intraoperative computed tomography launched following the U.S. Food and Drug Administration (FDA) and European CE mark clearance in 2013. VISIUS iCT is movable in operating room (OR) in about 30 seconds, which helps to ease workflow and provides reliable diagnostic quality with personalized dose management to take better decision and procedure guidance. Therefore, new device launches and strategic treatment portfolio is expected to fuel the growth of the intraoperative imaging market over the forecast period. Browse 34 Market Data Tables and 28 Figures spread through 140 Pages and in-depth TOC on intraoperative imaging market by device type (mobile C-arms, intraoperative MRI, intraoperative CT, intraoperative ultrasound), by application (neurosurgery, orthopedic surgery, spine Surgery, cardiovascular, ENT, Gastro and Others), by end user (hospitals, and ambulatory surgical centers), and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2025

To know the latest trends and insights prevalent in the intraoperative imaging market, click the link below:

https://www.coherentmarketinsights.com/market-insight/intraoperative-imaging-market-994

Key Takeaways of the Intraoperative Imaging Market:

• The global intraoperative imaging market is expected to expand at a CAGR 4.7% during the forecast period (2017 – 2025) due to the high global demand.
• Among device type, intraoperative MRI segment hold a dominant position in the global intraoperative imaging market, as intraoperative MRI can differentiate more accurately between tumor tissue and normal tissue while performing neurosurgery.
• Neurosurgery is the major application area of the global intraoperative imaging market, owing to the increasing incidences of brain tumors and central nervous system tumors.

Some of the key players involved in global intraoperative imaging market are Siemens AG, Medtronic plc, Koninklijke Philips NV, General Electric Company, IMRIS, Deerfield Imaging, Inc., Neurologica Corporation (Samsung Electronics Co., Ltd), Ziehm Imaging GmbH, and Brainlab AG.